Specify a stock or a cryptocurrency in the search bar to get a summary
Benitec Biopharma Ltd ADR
BNTCBenitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California. Address: 3940 Trust Way, Hayward, CA, United States, 94545
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BNTC
Dividend Analytics BNTC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
1 %Dividend History BNTC
Stock Valuation BNTC
Financials BNTC
Results | 2019 | Dynamics |